Dr. John Cush RheumNow
1 year 2 months ago
Emulation trials in SLE: Real or Fake?
Recently a landmark paper was published in A&R studying the results of an emulation trial. My colleagues and I were able to write an editorial on this paper and describe emulation trials.
https://t.co/0ulYG5xz0J https://t.co/y2jo2SSH83
Dr. John Cush RheumNow
1 year 2 months ago
SLE Perspectives: Past, Present, Future
https://t.co/ggYmVvEtZx https://t.co/VriDjAEcl5
Dr. John Cush RheumNow
1 year 2 months ago
Comparing EULAR (2025) and ACR (2020) Guidelines on Safety of Lupus Medications in Pregnancy Attendees at the 2025 RheumaPreg meeting were excited to discuss the newly released EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation. https://t.co/csd0FE08ZO
Dr. John Cush RheumNow
1 year 2 months ago
Risk Factors for Knee Osteoarthritis
New research from the University of Sydney reveals that obesity, having a knee injury and occupational risks such as shift work and lifting heavy loads are primary causes of knee osteoarthritis.
https://t.co/Kc686Zc8Xa https://t.co/ANyiE2pIxo
Dr. John Cush RheumNow
1 year 2 months ago
New Steroid Rules in Lupus? Letβs Talk.
Dr. Michelle Petri breaks down the latest strategies to minimize steroid exposure while managing disease activity in lupus patients.
π‘ Smarter steroid use = better outcomes.
π Watch now on RheumNow:
https://t.co/vbjrXAlixz
#Lupus https://t.co/TN5EkZhbef
Dr. John Cush RheumNow
1 year 2 months ago
π Lupus Unlocked: Antiphospholipid Syndrome
π
Tuesday, May 20, 2025 | π Time: 6:00 PM CT | 7:00 PM ET | 4:00 PM PT
Live Webinar w/ Q&A
Register Today: https://t.co/71NJsmBNf3
Livestream: X, LinkedIn, YouTube, Facebook
This session is designed to provide practical insights https://t.co/jAtduyzl0l
Dr. John Cush RheumNow
1 year 2 months ago
FDA approved the chikungunya virus vaccine (Ixchiq) in 11/23, but recently announced caution and pause use while it investigates Postmarketing Safety Reports of 17 SAE (cardiac & neurologic) & 2 deaths. 6 SAE in the USA, elderly w/ chronic med conditions. ~80K doses of Ixchiq https://t.co/RED8Xab0Ir
Dr. John Cush RheumNow
1 year 2 months ago
3-year, RCT of Mediteranean diet vs usual care in 924 older adults w/ metabolic syndrome & BMI > 27. Med. diet shows signif wt loss (3.4% vs 0.4%), w/ improved BMD (by DEXA) at year 3, especially in women. https://t.co/mllx6l1QnM https://t.co/I5e8PXX2oX
Dr. John Cush RheumNow
1 year 2 months ago
Clinical Impacts of the Pre Lupus State on Pregnancy Outcomes
Dr. Catherine Sims talks with Dr. Jessica English at the RheumaPreg 2025 meeting in Vienna, Austria.
https://t.co/T8ZYQtDNmZ https://t.co/PmVRFVlABd
Dr. John Cush RheumNow
1 year 2 months ago
Smoking & Autoantibodies in Rheumatoid Arthritis
Investigators from the Netherlands have published their findings that smoking is a risk factor in rheumatoid arthritis (RA), led by the induction of local autoimmune responses at mucosal sites (in the lungs) and exemplified by https://t.co/SQa3PrRnOI
Dr. John Cush RheumNow
1 year 2 months ago
Deep remission in SLE β what is it, and can we achieve it?
Recent reports on lupus patients treated with CAR-T cells targeting CD19+ B lymphocytes have sparked excitement. This is due to the patients experiencing ongoing clinical remission without further treatment after two https://t.co/rdBkIhfWWd

